Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2683150

Words JIBRELSO
Image
Image description
Status registered: Registered/protected
Priority date 06 Feb 2026 (Convention)
Class 5
Kind Word
Dates
Renewal due 04 Aug 2036
Registration advertised / published 19 Oct 2026
Entered on Register 19 Oct 2026
Acceptance advertised / published 10 Aug 2026
Acceptance 10 Aug 2026
Filing 04 Aug 2026
Registered from 04 Aug 2026

Owner Address for service
Bristol-Myers Squibb Company
Spruson & Ferguson

Goods & Services
Class 5: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer's disease, autism spectrum disorder, and musculoskeletal and skin diseases; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.

Convention details
Date 06 Feb 2026
Number 99639512
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Indexing constituents
Word Image